Skip to content
10-K

Annual Report

Autonomix Medical, Inc. AMIX

0001437749-26-018573

← back to feed
Filed
May 27, 2026 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding FY 2026 · May 21, 2026 11.41M sh
Capex FY 2026 · Mar 31, 2026 $10K
Capex FY 2026 · Mar 31, 2025 $14K
Operating Cash Flow FY 2026 · Mar 31, 2026 −$12.28M
Operating Cash Flow restated FY 2026 · Mar 31, 2025 −$8.26M
Cash And Equivalents FY 2026 · Mar 31, 2026 $7M
Cash And Equivalents FY 2026 · Mar 31, 2025 $9.14M
Stockholders Equity FY 2026 · Mar 31, 2026 $5.9M
Stockholders Equity FY 2026 · Mar 31, 2025 $8.1M
Stockholders Equity FY 2026 · Mar 31, 2024 $7.63M
Current Liabilities FY 2026 · Mar 31, 2026 $1.71M
Current Liabilities FY 2026 · Mar 31, 2025 $1.71M
Total Liabilities FY 2026 · Mar 31, 2026 $1.71M
Total Liabilities FY 2026 · Mar 31, 2025 $1.71M
Current Assets FY 2026 · Mar 31, 2026 $7.58M
Current Assets FY 2026 · Mar 31, 2025 $9.61M
Total Assets FY 2026 · Mar 31, 2026 $7.6M
Total Assets FY 2026 · Mar 31, 2025 $9.81M
Eps Basic FY 2026 · Mar 31, 2026 −$2.32
Eps Basic FY 2026 · Mar 31, 2025 −$6.46
Sga Expense FY 2026 · Mar 31, 2026 $9.89M
Sga Expense FY 2026 · Mar 31, 2025 $6.86M
Rd Expense FY 2026 · Mar 31, 2026 $7.14M
Rd Expense FY 2026 · Mar 31, 2025 $4.73M
Net Income FY 2026 · Mar 31, 2026 −$16.72M
Net Income FY 2026 · Mar 31, 2025 −$11.41M
Operating Income FY 2026 · Mar 31, 2026 −$17.03M
Operating Income FY 2026 · Mar 31, 2025 −$11.59M
Revenue FY 2026 · Mar 31, 2026 $0
Revenue FY 2026 · Mar 31, 2025 $0